ENGENE HOLDINGS INC. COMMON STOCK
NASDAQ: ENGN (enGene Therapeutics Inc.)
Last update: 1 hour ago1.96
0.04 (2.08%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | enGene Therapeutics Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | 3.0 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 2.00 |
|
enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 13.63% |
| % Held by Institutions | 77.57% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Siren, L.L.C. | 30 Jun 2026 | 6,256,662 |
| Nextech Invest Ltd. | 30 Jun 2026 | 2,324,943 |
| Acorn Capital Advisors, Llc | 30 Jun 2026 | 1,271,257 |
| Sr One Capital Management, Lp | 30 Jun 2026 | 747,750 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| GROSSMAN WILLIAM | 2.05 | - | 5,102 | 10,459 |
| Aggregate Net Quantity | 5,102 | |||
| Aggregate Net Value ($) | 10,459 | |||
| Aggregate Avg. Buy ($) | 2.05 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| GROSSMAN WILLIAM | Officer | 22 Sep 2026 | Buy (+) | 5,102 | 2.05 | 10,459 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |